Insights

Filter By:

Kleinberg Kaplan’s Dov Kleiner featured in Practical Law The Journal, a Thomson Reuters publication

Kleinberg Kaplan Partner Dov Kleiner was featured in the Spring 2022 issue of Practical Law The Journal, a Thomson Reuters publication. In the State Q&A section, Dov offers perspectives on New York-specific processes related to the Assignments for the Benefit of Creditors (ABCs). He, along with other attorneys in Delaware, Florida and Michigan highlight filing…

Firm News | April 1, 2022 | Creditors’ Rights and Bankruptcy Litigation

Kleinberg Kaplan Partner Matthew Gold Assists State of Washington in Successful Challenge of Purdue Pharma Settlement

Kleinberg Kaplan Creditors’ Rights and Bankruptcy Litigation partner Matthew J. Gold has been representing the State of Washington in its highly publicized legal battle against Purdue Pharma, maker of OxyContin, a painkiller that allegedly contributed to the national opioid crisis. Kleinberg Kaplan senior counsel Robert Tuchman also advises on this matter. Today, the Attorney General…

Firm News | March 3, 2022 | Creditors’ Rights and Bankruptcy Litigation

Purdue Pharma Bankruptcy Plan Vacated by District Court in Victory for Appellants Represented by Kleinberg Kaplan

Kleinberg Kaplan Creditors’ Rights and Bankruptcy Litigation partner Matthew J. Gold and associate Robert Tuchman have been representing the states of Washington, Connecticut, Delaware, Rhode Island and Vermont in their highly publicized legal battle against Purdue Pharma, maker of OxyContin, a painkiller that allegedly contributed to the national opioid crisis. Most recently, Gold and Tuchman advised the states…

Firm News | December 17, 2021 | Creditors’ Rights and Bankruptcy Litigation

Kleinberg Kaplan Partner Matthew Gold Featured in Latest Coverage of Purdue Pharma Litigation

Kleinberg Kaplan Creditors’ Rights and Bankruptcy Litigation partner Matthew J. Gold has been representing the State of Washington, the State of Oregon and the District of Columbia in their highly publicized legal battle against Purdue Pharma, maker of OxyContin, a painkiller that allegedly contributed to the national opioid crisis. Matt’s argument during the bankruptcy trial…

Firm News | September 7, 2021 | Creditors’ Rights and Bankruptcy Litigation

Kleinberg Kaplan Representation of Objecting States in the Purdue Pharma Case Featured in New York Law Journal

Kleinberg Kaplan attorneys were featured in the New York Law Journal following the filing of an objection to the chapter 11 plan proposed by Purdue Pharma, a privately held pharmaceutical company that was owned mainly by members of the Sackler family. The plan would grant to the Sacklers blanket lifetime immunity related to any civil suits.…

Firm News | July 22, 2021 | Creditors’ Rights and Bankruptcy Litigation

Manichean Struggle: Reverse Veil-Piercing Authorized in Delaware

A recent decision from the Delaware Chancery Court has established, for the first time, that the remedy of reverse veil-piercing is recognized under Delaware law. The decision, Manichean Capital, LLC v. Exela Technologies, Inc., resolves a dispute regarding the availability of reverse veil-piercing and augments the remedies for minority shareholders dissenting from a merger. Background…

Client Alerts | June 2, 2021 | Creditors’ Rights and Bankruptcy Litigation

Mapping the Harbor: Additional Interpretation of the Bankruptcy Safe Harbor

A series of decisions (and a recent brief) have highlighted some of the new issues that are arising in Safe Harbor litigation. In particular, they show how the courts are wrestling with questions concerning: Which entity in a complex transaction is considered the “initial transferee” for Safe Harbor purposes? How are courts interpreting the Safe…

Client Alerts | March 24, 2021 | Creditors’ Rights and Bankruptcy Litigation

Safe Harbor Resource Center

Elements of the Safe Harbor Defense Section 546(e) of the Bankruptcy Code provides a safe harbor that bars certain avoidance actions/clawback actions (described below – “What types of actions are barred?”) regarding Qualifying Transactions (described below) that involve Qualifying Entities (described below). What types of actions are barred? Section 546(e) bars preference actions and constructive fraudulent…

FEATURED PUBLICATION | March 23, 2021 | Creditors’ Rights and Bankruptcy Litigation